2006
DOI: 10.1016/j.jaad.2005.09.047
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative evaluation and management in dermatologic surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
25
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 44 publications
(26 citation statements)
references
References 42 publications
0
25
0
1
Order By: Relevance
“…72 It is agreed that this relatively high risk of thrombotic complications outweighs the much lower risk of serious hemorrhagic complications with continued anticoagulant therapy. In 2002 it was reported that up to 80% of Mohs surgeons discontinued warfarin therapy perioperatively, compared with 44% in 2005 19,73 ; we anticipate that this percentage currently is far less. This finding represents a dramatic paradigm shift by dermatologic surgeons in the perioperative management of all anticoagulant therapies.…”
Section: Ethanolmentioning
confidence: 85%
See 4 more Smart Citations
“…72 It is agreed that this relatively high risk of thrombotic complications outweighs the much lower risk of serious hemorrhagic complications with continued anticoagulant therapy. In 2002 it was reported that up to 80% of Mohs surgeons discontinued warfarin therapy perioperatively, compared with 44% in 2005 19,73 ; we anticipate that this percentage currently is far less. This finding represents a dramatic paradigm shift by dermatologic surgeons in the perioperative management of all anticoagulant therapies.…”
Section: Ethanolmentioning
confidence: 85%
“…16,18 Although some studies have shown a lack of bleeding complications during cutaneous surgeries in patients taking warfarin, a meta-analysis encompassing a total of 1373 dermatologic surgery patients found that those taking warfarin were nearly 7 times as likely to have moderate to severe bleeding-related complications (Table III) compared with control subjects. 4,5,19 Furthermore, recent prospective studies have demonstrated a statistically significant increase in hemorrhagic complications in patients taking warfarin. 1 Certain patient characteristics have been identified in the Outpatient Bleeding Risk Index as validated risk factors for major spontaneous or perioperative bleeding events.…”
Section: Anticoagulants Warfarinmentioning
confidence: 99%
See 3 more Smart Citations